This webinar, co-hosted by Nasdaq Nordics and Advokatfirman Vinge, is designed to address and shed light on some of these key items to enable decision makers to more clearly assess whether a dual listing in the US is an option that should be considered.
C-suite executives and board members of Nordic life sciences companies will find this seminar/webinar especially helpful as they consider the strategic decision potentially to dual list, enabling them to explore with a panel of experts, relevant topics such as marketing, finance and legal, and also to learn first-hand from the practical experiences of executives and other professionals from a Nordic listed life sciences company that has recently gone through this process.
For more information and registration click here.
